Retapamulin
- Generic Name
- Retapamulin
- Brand Names
- Altabax
- Drug Type
- Small Molecule
- Chemical Formula
- C30H47NO4S
- CAS Number
- 224452-66-8
- Unique Ingredient Identifier
- 4MG6O8991R
Overview
Retapamulin, marketed by GlaxoSmithKline as the ointment Altabax, is an antibiotic for skin infections like impetigo. It was approved by the FDA in April 2007.
Background
Retapamulin, marketed by GlaxoSmithKline as the ointment Altabax, is an antibiotic for skin infections like impetigo. It was approved by the FDA in April 2007.
Indication
For use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes.
Associated Conditions
- Staphylococcal impetigo
- Streptococcal impetigo
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath